Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Colorado BioScience

22:47 EDT 16th October 2018 | BioPortfolio

Here are the most relevant search results for "Colorado BioScience" found in our extensive news archives from over 250 global news sources.

More Information about Colorado BioScience on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Colorado BioScience for you to read. Along with our medical data and news we also list Colorado BioScience Clinical Trials, which are updated daily. BioPortfolio also has a large database of Colorado BioScience Companies for you to search.

Showing News Articles 1–25 of 59 from Colorado BioScience

Friday 12th October 2018

Weekly Policy Update: Bioscience in Recent National and International News

A quick recap of bioscience in recent national and international news. President Trump recently signed a bill prohibiting pharmacy benefit managers from imposing “gag orders” on pharmacists that prevent them from informing patients when their medications would be cheaper out of pocket. HHS Secretary Alex Azar has promised more actions on drug pricing in the near future. ...

Monday 8th October 2018

Prima-Temp Has Acquired Kindara, a Fellow Boulder-Based Women’s Healthtech Company

Prima-Temp, a women's healthtech company, has acquired Kindara, another Boulder-based women’s healthtech company. Kindara makes an app and Bluetooth-connected thermometer to help women track their fertility and create a community of other women looking to monitor their health and ovulation. Prima-Temp makes the Priya, a data-tracking medical device inserted inside a woman to continuously mo...

Wednesday 3rd October 2018

Weekly Policy Update: Advancing Innovation in Digital Health

Over the last year, in fact, FDA Commissioner Scott Gottlieb has put an emphasis on speeding up the process in getting technology and medications out to the public. This is evidenced by the new Pre- Certification program which would uproot the way software as a medical device is regulated, with the possibility of deeming a company safe instead of focusing on each individual product. T...

Friday 28th September 2018

Weekly Policy Update: The September Report

Today, the September Focus newsletter was published for a more detailed look at policy, and other issues, please read Jennifer’s monthly policy update.

Friday 21st September 2018

Weekly Policy Update: Advocating for Medicare Part D

The Colorado Bioscience Association along with We Work for Health Colorado, Epilepsy Foundation, Colorado Gerontological Society, Scleroderma Foundation, Rocky Mountain Stroke Center and the Colorado Business Roundtable sent a letter to the Colorado delegation regarding Medicare Part D. We voiced our concern about recent changes to Medicare Part D, contained in the Bipartisan Budget Act ...

Friday 14th September 2018

Weekly Policy Update: Dianne Primavera and Lang Sias Address the Colorado Life Science Innovation Forum

The Colorado Life Science Innovation Forum is filling the Westin Westminster with interesting speakers, enlightening panelists, and Colorado’s two Lieutenant Governor candidates throughout the day today. The event welcomed Dianne Primavera, running mate for Jared Polis, Democrat Candidate for Governor, and Lang Sias, running mate for Walker Stapleton, Republican Candidate for Governor. ...

Friday 7th September 2018

Weekly Policy update: Lieutenant Governor Candidates At The Colorado Life Science Innovation Forum and The State of Medicare

Colorado Life Science Innovation Forum – Keynote Featuring Remarks by Gubernatorial Running Mates Join CBSA on September 14th at the Colorado Life Science Innovation Forum.Our keynote lunch speakers include a 2018 Economic Update for Colorado presented by: Patty Silverstein , President & Chief Economist, Development Research Partners followed by major party Gube...

Thursday 30th August 2018

Weekly Policy Update: A Month In Policy and Bioscience In the News

Today, the August Focus newsletter was published for a more detailed look at policy, and other issues, please read Jennifer’s monthly policy update. BIOSCIENCE IN THE NEWS  Energy and Commerce News WASHINGTON, DC – On September 5, 2018, the Health Subcommittee, will have a hearing entitled, “Opportunities to Improve Health Care”. During this hearing the committee will

Friday 24th August 2018

Weekly Policy Update: The FDA’s Initiatives For Medical Devices and the Upcoming Gubernatorial Candidate Forum

FDA releases three important initiatives for medical device development, innovation and safety The FDA announced it is taking steps to advance innovation and surveillance for medical devices through the implementation of three initiatives related to the recent user fee re-authorization. In its first initiative, the FDA finalized the Voluntary Malfunction Summary Reporting Program, which ...

Friday 17th August 2018

Weekly Policy Update: FDA Releases New Draft Guidance and the Midwest BIO CSBA Retreat

FDA Releases New Draft Guidance to advance and modernize oncology drug trials In the FDA’s ongoing effort to modernize and create a more efficient approval process, last Friday the FDA released their draft guidance to advance and modernize oncology drug trials, “Expansion Cohorts: Use in First-In-Human Clinical Trials to Expedite Development of Oncology Drugs and Biologics”. The dra...

Friday 10th August 2018

Weekly Policy Update: FDA Funding and Other News

FDA Receives Funding in Senate Passed Appropriations Bill Last week the U.S. Senate overwhelmingly passed a $154.2 billion spending bill that includes more than $3 billion for the FDA. When industry fees are included, the FDA would have $5.49 billion in total funding next year. H.R. 6147 is the seventh appropriations bill the Senate has passed this year for the 2019 fiscal year, leaving tw...

Friday 3rd August 2018

Weekly Policy Update: Medical Device Tax and Colorado State Budget

  Scott Larson, VP, Legal and General Counsel, Terumo BCT; Jenna Hutchins, Territory Manager, ResMed; Congresswoman Dianna Degette; April Giles, President, CBSA; Jonathan Toronto, Vice President, Associate General Counsel, Zimmer Biomet; Andrea Autobee-Trujillo, Deputy District Director for Congresswoman Degette The July Focus newsletter was published this week with coverage on the medical d...

Friday 27th July 2018

Weekly Policy Update: House Repeals Medical Device Tax

On behalf of Colorado BioScience Association thank you for your efforts to secure a yes vote on H.R. 184 - Protect Medical Innovation Act of 2017. We appreciate the time you took to advocate to your representative on the importance of a permanent repeal of the medical device tax credit. In part due to your efforts, this week the U.S. House of Representatives passed H.R. 184, the standalon...

Friday 20th July 2018

Weekly Policy Update: Full Repeal of the Medical Device Tax Advocacy

This has been another week with persistent advocacy for full repeal of the Medical device tax in standalone legislation. A permanent repeal of the medical device excise tax remains a top priority for CBSA and Colorado's medtech innovators. While we are appreciative of temporary relief through the two- year suspension as part of the Continuing Resolution to fund the federal government, that...

Monday 16th July 2018

Colorado BioScience Association Announces Departure of President & CEO, April Giles

Board of Directors to Begin National Search for Replacement DENVER – Colorado BioScience Association (CBSA) announces the departure of longtime President & CEO April Giles. She served CBSA for more than 12 years, providing operational leadership before assuming the President & CEO role in 2012, and will stay with CBSA until August 30. Scott Larson, Chairman of the CBSA Board of Direc...

Friday 13th July 2018

Weekly Policy Update: Medical Device Tax Advocacy and the CACI Legislative Candidate Interviews

CBSA continues to advocate for a full repeal of the Medical device tax in standalone legislation. A permanent repeal of the tax remains a top priority for CBSA and Colorado's medtech innovators. While we are appreciative for temporary relief through the two-suspension as part of the Continuing Resolution to fund the federal government, the suspension is set to expire on December 31, 2019.&...

Friday 6th July 2018

Weekly Policy Update: Meeting with Congresswoman Degette

This week Colorado BioScience Association along with AdvaMed, our Board Chair Scott Larson at Terumo BCT, Zimmer Biomet and ResMed met with Congresswoman DeGette. The meeting offered a great opportunity to talk about the importance of our industry and the exciting innovations taking place, as well as barriers presenting current challenges. As a senior member of the House Energy &...

Thursday 28th June 2018

Weekly Policy Update: Primary Elections, Congratulating Sen. Gardner, and Drug Pricing

2018 COLORADO PRIMARY ELECTION With the anticipated Colorado Primary Election this week, we learned the long-awaited results of who would be our top two democratic and republican candidates for Governor. This was a crowded race with the Democratic party candidate Jared Polis and the Republican Party candidate Walker Stapleton winning the nominations. For more information on the races for state se...

Wednesday 27th June 2018

Sapphire Technology Completes a Nationwide Distribution Agreement With Burkhart Dental Supply

Denver-based dental instrument company, Sapphire Technology, recently completed a nationwide distribution agreement with Burkhart Dental Supply (Tacoma, WA). Burkhart will soon market and sell Sapphire’s innovative and proprietary line of SGS® sapphire-tipped composite dental instruments. Established in 1888, Burkhart is one of the oldest and most established distributors of dental prod...

Monday 25th June 2018

New Office Location Helps Packaging Compliance Labs Accelerate Growth In Healthcare Packaging

Packaging Compliance Labs, a top medical device and pharmaceutical packaging engineering and validation firm, recently opened a new office in the heart of downtown Denver, Colorado, to accommodate rapid growth and leverage the area’s growing biotechnology industry. In addition to the headquarters in Grand Rapids, Michigan, the new office space grows PCL’s geographic footprint and supports...

Thursday 21st June 2018

Weekly Policy Update: FDA Releases Important Guidances

The FDA recently announced the release of an important guidances, “Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities–Questions and Answers,” and “Medical Product Communications That Are Consistent With the FDA-Required Labeling”. The first guidance answers common questions about companies’ communications to payors, including...

Friday 15th June 2018

Weekly Policy Update: Drug Pricing News

This week HHS Secretary Alex Azar appeared in front of the Senate Health, Education, Labor and Pensions Committee for a hearing on drug pricing. Secretary Azar’s prepared testimony in large part summarized President Trump’s blue print. For more information on the blueprint click here and to view the full hearing click h

Friday 8th June 2018

Weekly Policy Update: BIO International Convention

This week CBSA President and CEO April Giles and Vice President Jennifer Jones returned from the 2018 BIO International Convention in Boston, Massachusetts. This annual trip is a great opportunity to meet with CBSA member companies, industry partners, and other bioscience supporters. The convention also provides a venue where we can learn directly from industry leaders and share policy less...

Tuesday 5th June 2018

National Bioscience Industry Report Shows $2T Economic Impact, Accelerated Venture Capital Investment & Job Growth

A study released today at the BIO International Convention shows that the U.S. bioscience industry has reached $2 trillion in annual economic impact while maintaining accelerated venture capital investment and job growth numbers. Among U.S. technology sectors, the bioscience industry has held a leading position as an economic driver and job generator. The report, Investment, Innovation and...

Friday 1st June 2018

Weekly Policy Update: BIO International Convention and Voter Registration

POLICY UPDATES Yesterday the May Focus newsletter was published for a more detailed look at policy, and other issues, please read Jennifer’s monthly policy update in May’s Focus newsletter. 2018 BIO INTERNATIONAL CONVENTION On Saturday, Colorado BioScience Association President and CEO April Giles and Vice President Jennifer Jones depart for Boston, MA for the annual the 2018 BIO Interna...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks